Clinical Trial: Follow-up, Blinded-Outcomes Trial of Subjects Having Received IMP in Clinical Trial 64,185-202

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: A 4-Year Follow-up, Blinded-Outcomes Trial of Subjects Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202 Trial Number: 64,185-203 Trial Phase:

Brief Summary: Follow-up, Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202